Endo International’s subsidiary, Par Sterile Products, has entered an agreement to expand its sterile fill-finish manufacturing production capacity and capabilities at its Rochester, MI plant to support the U.S. government’s national defense efforts for the production of critical medicines advancing pandemic preparation.   Par Sterile’s Rochester facility will establish a new sterile fill-finish manufacturing asset capable of processing liquid or lyophilized products requiring Bios...